Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) ended Monday session in green amid volatile trading. The shares closed up +1.01 points or 3.48% at $30.02 with 1.25 million shares getting traded. Post opening the session at $28.89, the shares hit an intraday low of $28.70 and an intraday high of $30.06 and the price vacillated in this range throughout the day. The company has a market cap of $3.42 billion and the numbers of outstanding shares have been calculated to be 120.92 million shares.
Ionis Pharmaceuticals Inc (IONS) announced that management will present a company overview at the following investor conferences:
2016 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 in New York, NY
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company’s website. Please check www.ionispharma.com for the latest information.
A live webcast of the presentations will be available on the “Investors & Media” section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.
Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) ended Monday session in green amid volatile trading. The shares closed up +1.67 points or 1.52% at $111.64 with 431,158.00 shares getting traded. Post opening the session at $109.60, the shares hit an intraday low of $109.17 and an intraday high of $111.75 and the price vacillated in this range throughout the day. The company has a market cap of $9.63 billion and the numbers of outstanding shares have been calculated to be 89.54 million shares.
IDEXX Laboratories, Inc. (IDXX) announced that it will participate in the Raymond James 12th Annual North American Equities Conference. Michael Williams, PhD, Executive Vice President, is scheduled to make a presentation on the Company on Tuesday, September 13, 2016 at 12:45 p.m. BST/7:45 a.m. EDT, at the Four Seasons Hotel London at Park Lane, London, England. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.